Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen
Article Sidebar
Main Article Content
Coronary heart disease (CHD) is highly prevalent in patients with diabetes mellitus (DM), and remains the single most common cause of death among this population. Regrettably, a significant percentage of diabetics fail to perceive the classic symptoms associated with myocardial ischemia. Among asymptomatic diabetics, the prevalence of abnormal cardiac testing appears to be high, raging between 10% and 62%, and mortality is significantly higher in those with abnormal scans. Hence, the potential use of screening for CHD detection among asymptomatic DM individuals is appealing and has been recommended in certain circumstances. However, it was not until recently, that this question was addressed in clinical trials. Two studies randomized a total of 2,023 asymptomatic diabetics to screening or not using cardiac imaging with a mean follow up of 4.4 ± 1.4 years. In combination, both trials showed lower than expected annual event rates, and failed to reduce major cardiovascular events in the screened group compared to the standard of care alone. The results of these trials do not currently support the use of screening tools for CHD detection in asymptomatic DM individuals. However, these studies have important limitations, and potential explanations for their negative results that are discussed in this manuscript.
- Screening
- coronary heart disease
- diabetes
Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, united states, 1980-2012. JAMA. 2014; 312: 1218–26. DOI: https://doi.org/10.1001/jama.2014.11494
CDC . National diabetes statistics report. Atlanta, GA, U.S: Department of Health and Human Services; 2014.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England J Med. 1998; 339: 229-34. DOI: https://doi.org/10.1056/NEJM199807233390404
Zaccardi F, Khan H, Laukkanen JA. Diabetes mellitus and risk of sudden cardiac death: A systematic review and meta-analysis. Internat J Cardiol. 2014; 177: 535-37 DOI: https://doi.org/10.1016/j.ijcard.2014.08.105
Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Int Med. 2001; 161: 1717–23. DOI: https://doi.org/10.1001/archinte.161.14.1717
Cabin HS, Roberts WC. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ("silent") previous acute myocardial infarction. Am J Cardiol. 1982;50:677–681. DOI: https://doi.org/10.1016/0002-9149(82)91218-8
Torremocha F, Hadjadj S, Carrie F, Rosenberg T, Herpin D, Marechaud R. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: Prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab. 2001; 27: 49–57.
Le Feuvre CL, Barthelemy O, Dubois-Laforgue D, Maunoury C, Mogenet A, Baubion N, et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab. 2005; 31: 135–42. DOI: https://doi.org/10.1016/S1262-3636(07)70179-9
Sejil S, Janand-Delenne B, Avierinos JF, Habib G, Labastie N, Raccah D, et al. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. Diabetic medicine : J British Diabetic Assoc. 2006; 23: 1186–91. DOI: https://doi.org/10.1111/j.1464-5491.2006.01992.x
Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets-Schneider P, Stokkel MP, et al. van der Wall EE Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. Eur J Nuclear Med Mol Imag. 2009; 36: 567–75. DOI: https://doi.org/10.1007/s00259-008-0967-y
Choi EK, Chun EJ, Choi SI, Chang SA, Choi SH, Lim S, et al. Assessment of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes mellitus with single photon emission computed tomography and coronary computed tomography angiography. Am J Cardiol. 2009; 104: 890–6. DOI: https://doi.org/10.1016/j.amjcard.2009.05.026
Jacqueminet S, Barthelemy O, Rouzet F, Isnard R, Halbron M, Bouzamondo A, et al. A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients. Diabetes Metab. 2010;36: 463–9. DOI: https://doi.org/10.1016/j.diabet.2010.06.005
Giovacchini G, Cappagli M, Carro S, Borrini S, Montepagani A, Leoncini R, et al. Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients. Eur J Nuclear Med Mol Imag. 2013;40: 548–57. DOI: https://doi.org/10.1007/s00259-012-2323-5
De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002; 90: 827–32. DOI: https://doi.org/10.1016/S0002-9149(02)02702-9
Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: The j-access 2 investigation. Diabetes Care. 2010; 33: 2320–6. DOI: https://doi.org/10.2337/dc09-2370
Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005; 45: 43–9. DOI: https://doi.org/10.1016/j.jacc.2004.06.078
Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006; 47: 65–71. DOI: https://doi.org/10.1016/j.jacc.2005.10.008
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 accf/aha guideline for assessment of cardiovascular risk in asymptomatic adults: Executive summary: A report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2010; 122: 2748–64. DOI: https://doi.org/10.1161/CIR.0b013e3182051bab
Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The diad study. Diabetes Care. 2004; 27: 1954–61. DOI: https://doi.org/10.2337/diacare.27.8.1954
Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA. 2009; 301: 1547–55. DOI: https://doi.org/10.1001/jama.2009.476
Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using ct angiography on mortality and cardiac events in high-risk patients with diabetes: The factor-64 randomized clinical trial. JAMA. 2014; 312: 2234-43. DOI: https://doi.org/10.1001/jama.2014.15825
Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: Influence of age at onset, diabetes duration, and established and novel risk factors. Arch Int Med. 2011; 171: 404–10. DOI: https://doi.org/10.1001/archinternmed.2011.2
Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without pci for stable coronary disease. New England J Med. 2007; 356: 1503–16. DOI: https://doi.org/10.1056/NEJMoa070829
Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. New England J Med. 2009; 360: 2503–15. DOI: https://doi.org/10.1056/NEJMoa0805796
Downloads
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Roberto Jaramillo, Luz Stella García, Paco Eduardo Bravo, Aníbal Badel, Pablo Andrés Bravo, Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. , Colombia Medica: Vol. 34 No. 3 (2003)
Similar Articles
- Pablo Aschner, Oscar Mauricio Muñoz, Diana Giron, Olga Milena Garcia, Daniel Gerardo Fernandez-Ávila, luz angela casas, Luisa Fernanda Bohórquez, Clara María Arángo T., Liliana Carvajal, Doris Amanda Ramírez, Juan Guillermo Sarmiento, Cristian Alejandro Colon, Nestor Fabián Correa G., Pilar Alarcón R., Alvaro Andrés Bústamante S., Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. , Colombia Medica: Vol. 47 No. 2 (2016)
- Patricio López-Jaramillo, Carlos Calderón, Jorge Castillo, Iván Darío Escobar, Enrique Melgarejo, Gustavo Adolfo Parra, Prediabetes in Colombia: Expert Consensus , Colombia Medica: Vol. 48 No. 4 (2017)
- Martha Lucía Gallego, Nelsy Loango, Martha Lucía Gallego, Cardiovascular risk factors in first-degree relatives of patients with hypertension* , Colombia Medica: Vol. 42 No. 1 (2011)
- Martin Rebolledo Del Toro, Camila Borda, Luisa Fernanda Rincón, Andrea Castillo, Daniel Gerardo Fernández-Ávila, Recurrent acute coronary syndrome after infliximab infusion in a patient with rheumatoid arthritis , Colombia Medica: Vol. 54 No. 2 (2023)
- Luis Mariano Otero, Alvaro Muñoz, Lunevar Figueroa, Impact of moderating model of the risk in the chronic renal disease. IPS COMFANDI, Cali, 2006. , Colombia Medica: Vol. 38 No. 3 (2007)
- Carlos Andrés Pineda, Metabolic syndrome: definition, history, criterion , Colombia Medica: Vol. 39 No. 1 (2008)
- José Mauricio Ocampo, Self-rated health: Importance of use in elderly adults , Colombia Medica: Vol. 41 No. 3 (2010)
- Harry Pachajoa, Correspondence , Colombia Medica: Vol. 43 No. 1 (2012)
- Carlos A. Reyes Ortiz, Carlos H. Moreno, Lina M. Reyes, Alejandro Jordán, Diagnósticos más frecuentes en la consulta ambulatoria de geriatría del Hospital Universitario del Valle. , Colombia Medica: Vol. 31 No. 4 (2000)
You may also start an advanced similarity search for this article.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use